{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:02:01Z","timestamp":1790978521713,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1006\/clim.2001.5036","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"320-324","source":"Crossref","is-referenced-by-count":42,"title":["Five-Year Follow-up of Patients with Primary Antibody Deficiencies Following an Outbreak of Acute Hepatitis C"],"prefix":"10.1006","volume":"99","author":[{"given":"H.M.","family":"Chapel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.L.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Peach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.G.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2001.5036_RF1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2249.1997.508-ce1412.x","article-title":"Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year followup","volume":"110","author":"Christie","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2001.5036_RF2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.1996.v110.pm8613001","article-title":"Outbreak of acute hepatitis C following the use of anti-hepatitis C virus screened intravenous immunoglobulin therapy","volume":"110","author":"Healey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1006\/clim.2001.5036_RF3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(95)91002-6","article-title":"Hepatitis C transmission associated with intravenous immunoglobulins","volume":"345","author":"Yu","year":"1995","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5036_RF4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(86)90852-4","article-title":"Non-A non-B hepatitis after intravenous gammaglobulin [letter]","volume":"327","author":"Webster","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5036_RF5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(86)91081-0","article-title":"Non-A, non-B hepatitis after intravenous gammaglobulin [letter]","volume":"327","author":"Weiland","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5036_RF6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(87)90178-4","article-title":"Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy","volume":"329","author":"Thomson","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5036_RF7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(88)90016-2","article-title":"Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency","volume":"84","author":"Bjorkander","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1006\/clim.2001.5036_RF8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinaemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5036_RF9","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0168-8278(05)80436-2","article-title":"Treatment with interferons of community-acquired chronic hepatitis and cirrhosis type C","volume":"17","author":"Alberti","year":"1993","journal-title":"J. Hepatol."},{"key":"10.1006\/clim.2001.5036_RF10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(94)80128-2","article-title":"Prediction of response to interferon treatment of chronic hepatitis C","volume":"21","author":"Davis","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1006\/clim.2001.5036_RF11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840150504","article-title":"Interferon in acute post-transfusion hepatitis C: A randomised controlled trial","volume":"15","author":"Viladomiu","year":"1992","journal-title":"Hepatology"},{"key":"10.1006\/clim.2001.5036_RF12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840190105","article-title":"A multicenter randomized controlled trial of recombinant interferon-alpha in patients with acute transfusion-associated hepatitis C","volume":"19","author":"Lampertico","year":"1994","journal-title":"Hepatology"},{"key":"10.1006\/clim.2001.5036_RF13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/clim.1999.4798","article-title":"Diagnostic criteria for the primary immune deficiency disease","volume":"93","author":"Conley","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1006\/clim.2001.5036_RF14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-127-10-199711150-00003","article-title":"Long term histologic improvement and loss of detectable intrahepatic HCV-RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy","volume":"127","author":"Marcellin","year":"1997","journal-title":"Ann. Int. Med."},{"key":"10.1006\/clim.2001.5036_RF15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","article-title":"Long term mortality after transfusion associated non-A, non-B hepatitis","volume":"327","author":"Seef","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5036_RF16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.1840190104","article-title":"Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease","volume":"19","author":"Dusheiko","year":"1994","journal-title":"Hepatology"},{"key":"10.1006\/clim.2001.5036_RF17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00005","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"127","author":"Mechanic","year":"1997","journal-title":"Ann. Int. Med."},{"key":"10.1006\/clim.2001.5036_RF18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5036_RF19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5036_RF20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0016-5085(95)90464-6","article-title":"Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency","volume":"108","author":"Smith","year":"1995","journal-title":"Gastroenterology"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:52:15Z","timestamp":1557312735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661601950363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521661601950363"],"URL":"https:\/\/doi.org\/10.1006\/clim.2001.5036","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}